Regenerative medicine focuses on supporting the body’s natural ability to repair, maintain, and rebuild damaged tissues using biologics, cellular signaling, and supportive therapies.
Traditional treatments often focus on symptom management or structural replacement, while regenerative medicine aims to support the body’s own repair processes.
Biologics are materials derived from living tissues or cells that may provide growth factors, signaling molecules, structural proteins, or regenerative cells.
The body performs the repair work itself. Regenerative biologics provide support, signaling, and materials that may help the repair process function more effectively.
Platelet-rich plasma (PRP) therapy uses concentrated platelets from your own blood to provide growth factors that support tissue repair and healing.
MSCs are connective tissue cells that help support repair processes, immune regulation, and cellular communication within the body.
MSCs are often called stem cells, but they have more limited differentiation abilities than embryonic stem cells and are more accurately described as mesenchymal stromal cells.
MSCs may be sourced from bone marrow, adipose (fat) tissue, umbilical cord tissue, placenta, and other connective tissues.
Different MSC sources have different biological characteristics, including cell yield, immune signaling behavior, and regenerative potential.
Exosomes are tiny membrane-bound vesicles released by cells that carry proteins, RNA, lipids, and signaling molecules involved in cellular communication.
Exosomes help cells communicate and may influence inflammation, tissue repair, and immune responses.
No. Exosome products can vary significantly in purity, manufacturing standards, source material, and scientific characterization.
The MISEV guidelines are international standards developed to help verify and characterize true exosome preparations.
Regenerative approaches may help support the body’s repair response in certain mild to moderate knee conditions by supporting tissue healing and inflammation regulation.
Conditions commonly evaluated include mild to moderate osteoarthritis, tendon irritation, ligament strain, cartilage wear, and chronic joint inflammation.
Some regenerative approaches are being explored for certain spine-related conditions involving discs, joints, ligaments, muscles, and inflammation associated with chronic lower back discomfort.
Cortisone injections primarily suppress inflammation temporarily, while regenerative therapies aim to support the body’s natural repair environment.
In some mild to moderate cases, regenerative therapies may help delay or reduce the need for surgery, though severe structural damage may still require surgical treatment.
Because tissue remodeling occurs gradually, some patients may notice improvements over several weeks to several months.
Outcomes depend on many factors, including inflammation levels, metabolic health, age, nutrition, sleep quality, lifestyle habits, and the severity of tissue damage.
Chronic inflammation can interfere with tissue repair by shifting the body toward a destructive rather than constructive healing environment.
No. Regenerative medicine is not considered a cure for arthritis, but it may help support tissue health and symptom management in some patients.
Yes. Researchers are studying how MSCs and exosomes interact with nerve tissue, inflammation, and cellular signaling related to peripheral nerve health.
Neuropathy is complex and often linked to underlying systemic conditions. Research in regenerative medicine for neuropathy is still developing, and patients should work closely with qualified neurologists.
Many regenerative biologics operate within FDA regulatory frameworks, but most are not FDA-approved to cure or treat specific diseases.
Patients should look for providers who explain realistic expectations, discuss scientific evidence clearly, review overall health factors, and provide documentation regarding product sourcing and quality.
Patients should ask:
Potential candidates may include individuals with mild to moderate joint pain, chronic inflammation, soft tissue injuries, or degenerative conditions seeking non-surgical supportive care options.
No. Regenerative medicine does not reverse biological aging or make someone biologically younger.
One of the biggest misconceptions is that regenerative medicine “magically” repairs tissues on its own. In reality, the body performs the repair work, while biologics help support the repair environment through signaling and structural support.